CKS2
Cyclin-dependent kinases regulatory subunit 2
Also known as: CKS2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P33552
- Gene
- CKS2
- Ensembl
- ENSG00000123975
- Chromosome
- 9
- Canonical length
- 79 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Mitochondria,Cytosol
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
CKS2 protein binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function. The CKS2 mRNA is found to be expressed in different patterns through the cell cycle in HeLa cells, which reflects specialized role for the encoded protein. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
79 residues, UniProt reviewed canonical sequence.
>P33552|CKS2
1 MAHKQIYYSD KYFDEHYEYR HVMLPRELSK QVPKTHLMSE EEWRRLGVQQ SLGWVHYMIH
61 EPEPHILLFR RPLPKDQQKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CKS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 176 nTPM
Expression across tissuesHPA
Tissue
- testis: 176 nTPM
- bone marrow: 167 nTPM
- thymus: 113 nTPM
- lymph node: 96 nTPM
- tonsil: 79 nTPM
- adrenal gland: 78 nTPM
Single-cell type
- late primary spermatocytes: 1,010 nCPM
- oocytes: 741 nCPM
- differentiating spermatogonia: 610 nCPM
- early primary spermatocytes: 578 nCPM
- gastric progenitor cells: 481 nCPM
- granulosa cells: 440 nCPM
Immune cell
- plasmacytoid DC: 188 nTPM
- T-reg: 63 nTPM
- memory B-cell: 62 nTPM
- naive B-cell: 45 nTPM
- eosinophil: 44 nTPM
- basophil: 41 nTPM
Brain region
- cerebral cortex: 15 nTPM
- hippocampal formation: 9.1 nTPM
- choroid plexus: 8.3 nTPM
- cerebellum: 7.6 nTPM
- white matter: 6.4 nTPM
- pons: 6.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CKS2.
Disease | ImmuneIEDB
Conditions an epitope on CKS2 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0.42
- gnomAD missense Z
- 1.28
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- fibroblast proliferation
- meiosis I
- mitotic cell cycle phase transition
- regulation of mitotic cell cycle
- regulation of transcription by RNA polymerase II
Molecular functions
- chromatin binding
- cyclin-dependent protein serine/threonine kinase activator activity
- histone binding
- protein kinase binding
- ubiquitin binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CKS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CKS2 as an antibody target. Whether an autoantibody or antibody against CKS2 could matter depends on whether native CKS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CKS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CKS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...